6.
Heyer C, Sundsbak J, Abebe K, Chapman A, Torres V, Grantham J
. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2016; 27(9):2872-84.
PMC: 5004648.
DOI: 10.1681/ASN.2015050583.
View
7.
Harris P, Rossetti S
. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010; 6(4):197-206.
PMC: 4050432.
DOI: 10.1038/nrneph.2010.18.
View
8.
Cornec-Le Gall E, Audrezet M, Rousseau A, Hourmant M, Renaudineau E, Charasse C
. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2015; 27(3):942-51.
PMC: 4769200.
DOI: 10.1681/ASN.2015010016.
View
9.
Pei Y, Obaji J, Dupuis A, Paterson A, Magistroni R, Dicks E
. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2008; 20(1):205-12.
PMC: 2615723.
DOI: 10.1681/ASN.2008050507.
View
10.
Chapman A, Devuyst O, Eckardt K, Gansevoort R, Harris T, Horie S
. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015; 88(1):17-27.
PMC: 4913350.
DOI: 10.1038/ki.2015.59.
View
11.
Rossetti S, Kubly V, Consugar M, Hopp K, Roy S, Horsley S
. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int. 2009; 75(8):848-55.
PMC: 2813773.
DOI: 10.1038/ki.2008.686.
View
12.
Wilson P
. Polycystic kidney disease. N Engl J Med. 2004; 350(2):151-64.
DOI: 10.1056/NEJMra022161.
View
13.
Rossetti S, Burton S, Strmecki L, Pond G, San Millan J, Zerres K
. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol. 2002; 13(5):1230-7.
DOI: 10.1097/01.asn.0000013300.11876.37.
View
14.
Rossetti S, Consugar M, Chapman A, Torres V, Guay-Woodford L, Grantham J
. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2007; 18(7):2143-60.
DOI: 10.1681/ASN.2006121387.
View
15.
Parfrey P, Bear J, Morgan J, Cramer B, McManamon P, GAULT M
. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med. 1990; 323(16):1085-90.
DOI: 10.1056/NEJM199010183231601.
View
16.
Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L
. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol. 1996; 7(10):2142-51.
DOI: 10.1681/ASN.V7102142.
View
17.
Hateboer N, v Dijk M, Bogdanova N, Coto E, Saggar-Malik A, San Millan J
. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet. 1999; 353(9147):103-7.
DOI: 10.1016/s0140-6736(98)03495-3.
View
18.
Harris P, Torres V
. Polycystic kidney disease. Annu Rev Med. 2008; 60:321-37.
PMC: 2834200.
DOI: 10.1146/annurev.med.60.101707.125712.
View
19.
Harris P, Rossetti S
. Determinants of renal disease variability in ADPKD. Adv Chronic Kidney Dis. 2010; 17(2):131-9.
PMC: 2837603.
DOI: 10.1053/j.ackd.2009.12.004.
View
20.
Parsa A, Kao W, Xie D, Astor B, Li M, Hsu C
. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013; 369(23):2183-96.
PMC: 3969022.
DOI: 10.1056/NEJMoa1310345.
View